Involvement of p53 in phthalate effects on mouse and rat osteoblasts

Journal of Cellular Biochemistry

Volumn 107, Issue 2, 2009, Pages 316-327

  Sabbieti, M G ^a   Agas, D ^a   Santoni, G ^a   Materazzi, S ^b   Menghi, G ^a   Marchetti, L ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Apoptosis; Bone; p53; Phthalates; Sirna

Indexed keywords

CYCLIN D3; CYCLIN DEPENDENT KINASE 4; DNA BASE; MYC PROTEIN; PHOSPHOPROTEIN; PHTHALIC ACID BENZYL BUTYL ESTER; PHTHALIC ACID DIBUTYL ESTER; PROTEIN BAX; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL METABOLISM; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; MALE; MOUSE; NEWBORN; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; RAT; RNA INTERFERENCE;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL SURVIVAL; DIBUTYL PHTHALATE; DNA DAMAGE; IMAGE PROCESSING, COMPUTER-ASSISTED; MICE; MICROSCOPY, CONFOCAL; MICROSCOPY, IMMUNOELECTRON; OSTEOBLASTS; PHTHALIC ACIDS; PLASTICIZERS; PROTO-ONCOGENE PROTEINS C-MYC; RATS; TUMOR SUPPRESSOR PROTEIN P53;

RATTUS;

EID: 66149113192     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22127     Document Type: Article

References (52)

1. Agas D, Sabbieti MG, Capacchietti M, Materazzi S, Menghi G, Materazzi G, Hurley MM, Marchetti L. 2007. Benzyl butyl phthalate influences actin distribution and cell proliferation in rat Py1a osteoblasts. J Cell Biochem 101:543-551.
2. Attardi LD, Reczek EE, Cosmas C, Demicco EG, McCurrach ME, Lowe SW, Jacks T. 2000. PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family. Genes Dev 14:704-718.
3. Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y, Ziv Y. 1998. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281:1674-1677.
4. Beier R, Bürgin A, Kiermaier A, Fero M, Karsunky H, Saffrich R, Möröy T, Ansorge W, Roberts J, Eilers M. 2000. Induction of cyclin E-cdk2 kinase activity, E2F-dependent transcription and cell growth by Myc are genetically separable events. EMBO J 19:5813-5823.
5. Berns K, Hijmans EM, Koh E, Daley GQ, Bernards R. 2000. A genetic screen to identify genes that rescue the slow growth phenotype of c-myc null fibroblasts. Oncogene 19:3330-3334.
6. Born TL, Frost JA, Schönthal A, Prendergast GC, Feramisco JR. 1994. c-Myc cooperates with activated Ras to induce the cdc2 promoter. Mol Cell Biol 14:5710-5718.
7. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW, Vogelstein B. 1998. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282:1497-1501.
8. Cotton J, Spandau DF. 1997. Ultraviolet B-radiation dose influences the induction of apoptosis and p53 in human keratinocytes. Radiat Res 147:148-155.
9. Dewey WC, Ling CC, Meyn RE. 1995. Radiation-induced apoptosis: Relevance to radiotherapy. Int J Radiat Oncol Biol Phys 33:781-796.
10. Ema M, Itami T, Kawasaki H. 1993. Teratogenic phase specificity of butyl benzyl phthalate in rats. Toxicology 79:11-19.
11. Fei P, El-Deiry WS. 2003. P53 and radiation responses. Oncogene 22:5774-5783.
12. Group EF, Jr. 1986. Environmental fate and aquatic toxicology studies on phthalate esters. Environ Health Perspect 65:337-340.
13. Guillette LJ, Jr., Guillette EA. 1996. Environmental contaminants and reproductive abnormalities in wildlife: Implications for public health? Toxicol Ind Health 12:537-550.
14. Harris CA, Henttu P, Parker MG, Sumpter JP. 1997. The estrogenic activity of phthalate esters. In Vitro Environ Health Perspect 105:802-811.
15. Hecht R, ConnellyM, Marchetti L, Ball WD, Hand AR. 2000. Cell death during development of intercalated ducts in the rat submandibular gland. Anat Rec 258:349-358.
16. Hirai H, Sherr CJ. 1996. Interaction of D-type cyclins with a novel myb-like transcription factor, DMP1. Mol Cell Biol 16:6457-6467.
17. Jobling S, Reynolds T, White R, Parker MG, Sumpter JP. 1995. A variety of environmentally persistent chemicals, including some phthalate plasticizers, are weakly estrogenic. Environ Health Perspect 103:582-587.
18. Kim YH, Buchholz MA, Chrest FJ, Nordin AA. 1994. Up-regulation of c-myc induces the gene expression of the murine homologues of p34cdc2 and cyclin-dependent kinase-2 in T lymphocytes. J Immunol 152:4328-4335.
19. Levine AJ. 1997. p53, the cellular gatekeeper for growth and division. Cell 88:323-331.
20. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X. 1997. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479-489.
21. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. 1996. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c. Cell 86:147-157.
22. Longnecker MP, Rogan WJ, Lucier G. 1997. The human health effects of DDT (dichlorodiphenyltrichloroethane) and PCBS (polychlorinated biphenyls) and an overview of organochlorines in public health. Annu Rev Public Health 18:211-244.
23. Malumbres M, Barbacid M. 2001. To cycle or not to cycle: A critical decision in cancer. Nat Rev Cancer 1:222-231.
24. Marchetti L, Sabbieti MG, Menghi M, Materazzi S, Hurley MM, Menghi G. 2002. Effects of phthalate esters on actin cytoskeleton of Py1a rat osteoblasts. Histol Histopathol 17:1061-1066.
25. Marchetti L, Sabbieti MG, Agas D, Menghi M, Materazzi G, Menghi G, Hurley MM. 2006. PGF2α increases FGF-2 and FGFR2 trafficking in Py1a rat osteoblasts via clathrin independent and importin β dependent pathway. J Cell Biochem 97:1379-1392.
26. Mayer FL, Stalling DL, Johnson JL. 1972. Phthalate esters as environmental contaminants. Nature 238:411-413.
27. Menghi G, Sabbieti MG, Marchetti L, Menghi M, Materazzi S, Hurley MM. 2001. Phthalate esters influence FGF-2 translocation in Py1a rat osteoblasts. Eur J Morphol 39:155-162.
28. Middeler G, Zerf K, Jenovai S, Thulig A, Tschodrich-Rotter M, Kubitscheck U, Peters R. 1997. The tumor suppressor p53 is subject to both nuclear import and export, and both are fast, energy-dependent and lectininhibited. Oncogene 14:1407-1417.
29. Montero A, Okada Y, Tomita M, Ito M, Tsurukami H, Nakamura T, Doetschman T, Coffin JD, Hurley MM. 2000. Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J Clin Invest 105:1085-1093.
30. Morgan SE, Kastan MB. 1997. p53 and ATM: Cell cycle, cell death, and cancer. Adv Cancer Res 71:1-25.
31. Morris SM, Akerman GS, Desai VG, Tsai C, Tolleson WH, Melchior WB, Lin C-J, Fuscoe JC, Casciano DA, Chen JJ. 2008. Effect of p53 genotype on gene expression profiles in murine liver. Mut Res 640:54-73.
32. Offer H, Erez N, Zurer I, Tang X, Milyavsky M, Goldfinger N, Rotter V. 2002. The onset of p53-dependent DNA repair or apoptosis is determined by the level of accumulated damaged DNA. Carcinogenesis 23:1025-1032.
33. Ohki R, Nemoto J, Murasawa H, Oda E, Inazawa J, Tanaka N, Taniguchi T. 2000. Reprimo, a new candidate mediator of the p53-mediated cell cycle arrest at the G2 phase. J Biol Chem 275:22627-22630.
34. Parfitt AM. 1987. Bone remodelling and bone loss-understanding the pathophysiology of osteoporosis. Clin Obstet Gynecol 30:789-811.
35. Pawley J. 1995. Fundamental limits in confocal microscopy. In: Pawley J, editor. Handbook of biological confocal microscopy. 2nd edition. New York and London: Plenum Press. pp. 19-37.
36. Quarles LD, Yohay DA, Lever LW, Caton R, Wenstrup RJ. 1992. Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: An in vitro model of osteoblast development. J Bone Miner Res 7:683-692.
37. Reinke V, Lozano G. 1997. Differential activation of p53 targets in cells treated with ultraviolet radiation that undergo both apoptosis and growth arrest. Radiat Res 148:115-122.
38. Rodan GA. 1992. Introduction to bone biology. Bone 13:S3-S6.
39. Ross GM. 1999. Induction of cell death by radiotherapy. Endocr Relat Cancer 6:41-44.
40. Sabbieti MG, Marchetti L, Curini R, Menghi G, Roda A, Russo MV, Nugnes C, Materazzi S. 2000. Evidence of butyl benzyl phtalate induced modifications in a model system developed in vitro. Analusis 28:843-846.
41. Safe SH. 1998. Interactions between hormones and chemicals in breast cancer. Annu Rev Pharmacol Toxicol 38:121-158.
42. Savitsky KA, Bar-Shira S, Gilad G, Rotman Y, Ziv L, Vanagaite DA, Tagle S, Smith T, Uziel S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NG, Taylor AM, Arlett CF, Miki T, Weissman SM, Lovett M, Collins FS, Shiloh Y. 1995. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268:1749-1753.
43. Sharman M, Read WA, Castle L, Gilbert J. 1994. Levels of di-(2-ethylhexyl) phthalate and total phthalate esters in milk, cream, butter and cheese. Food Addit Contam 11:375-385.
44. Sherr CJ, Roberts JM. 1999. CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev 13:1501-1512.
45. Shotton N. 1989. Confocal scanning optical microscopy and its applications for biological specimens. J Cell Science 94:175-206.
46. Siliciano JD, Canman CE, Taya Y, Sakaguchi K, Appella E, Kastan MB. 1997. DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev 11:3471-3481.
47. Stein GS, Lian JB. 1993. Molecular mechanisms mediating proliferation/ differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr Rev 14:424-442.
48. Tanaka H, Arakawa H, Yamaguchi T, Shiraishi K, Fukuda S, Matsui K, Takei Y, Nakamura Y. 2000. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature 404:42-49.
49. Vaux DL. 1997. CED-4 the third horseman of apoptosis. Cell 90:389-390.
50. Zajac-Kaye M. 2001. Myc oncogene: A key component in cell cycle regulation and its implication for lung cancer. Lung Cancer 2:S43-S46.
51. Zarkowska T, Mittnacht S. 1997. Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases. J Biol Chem 272:12738-12746.
52. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X. 1997. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90:405-413.